doi:10.48130/targetome-0026-0040

[1]

Duan Y, Zhao LJ, Lu YT, Li J, Li SX. 2025. Crosstalk between kidney and bones: New perspective for modulating osteoporosis. Ageing Research Reviews 109:102776

doi: 10.1016/j.arr.2025.102776

[2]

Morin SN, Leslie WD, Schousboe JT. 2025. Osteoporosis: A Review. Journal of the American Medical Association 334:894−907

doi: 10.1001/jama.2025.6003

[3]

Ye C, Ebeling P, Kline G. 2025. Osteoporosis. The Lancet 406:2003−2016

doi: 10.1016/S0140-6736(25)01385-6

[4]

Ishikawa K, Tani S, Sakai N, Kudo Y, Horiuchi H, et al. 2025. Mouse model of anti-RANKL discontinuation reveals reduced bone mass and quality through disruption of bone remodeling. Bone Research 13:56

doi: 10.1038/s41413-025-00433-0

[5]

Leder BZ, Ramchand SK, Jordan M, Ryan S, Patnaik A, et al. 2026. 3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial. The Lancet Diabetes & Endocrinology 14:216−222

doi: 10.1016/S2213-8587(25)00319-5

[6]

Shen Y, Benlabiod C, Watson E, Gurashi K, Fower A, et al. 2026. comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders. Cell Stem Cell 33:421−437. e7

doi: 10.1016/j.stem.2026.01.010

[7]

Li Y, Ji L, Yu J, Zhu F, Xiang Y, et al. 2026. Bioactive materials-mediated regulation of bone marrow microenvironment: mechanistic insights and therapeutic potentials. Advanced Materials 38:e11497

doi: 10.1002/adma.202511497

[8]

Qian R, Ge J, Fan N, Sun Z, Zhao C, et al. 2026. Natural products in cancer prevention and therapy: current challenges and future directions. MedComm 7:e70585

doi: 10.1002/mco2.70585

[9]

Choo MZY, Chua JAT, Lee SXY, Ang Y, Fred Wong WSF, et al. 2025. Privileged natural product compound classes for anti-inflammatory drug development. Natural Product Reports 42:856−875

doi: 10.1039/d4np00066h

[10]

Zhu Y, Li Q, Zhou Y, Wu D, Qin H, et al. 2026. Baiting-enhanced extravasation of lipid nanoparticles for targeted co-delivery of decitabine and siTNF-α to the bone marrow niche in leukemia therapy. Journal of Controlled Release 394:114874

doi: 10.1016/j.jconrel.2026.114874

[11]

Cheng X, Chen Y, Zhou X, Gu Q, Zhao H, et al. 2025. Immunoporosis: the hidden link between aging immune cells and bone fragility. Journal of Orthopaedic Translation 53:325−335

doi: 10.1016/j.jot.2025.06.015

[12]

Wang C, Wu Q, Zhuang L, Chen Y, Zhang Q, et al. 2026. Immunometabolism of macrophages in the bone microenvironment: a new perspective for bone healing therapy. Journal of Advanced Research 82:485−506

doi: 10.1016/j.jare.2025.07.046

[13]

Roy N, Liu H, Horenberg AL, Pathak AP, Chen J, et al. 2026. From complexity to clarity: aging bone marrow niche in bone and blood regeneration and malignancy. Bone Research 14:54

doi: 10.1038/s41413-026-00543-3

[14]

Zhao Y, Peng X, Wang Q, Zhang Z, Wang L, et al. 2024. Crosstalk between the neuroendocrine system and bone homeostasis. Endocrine Reviews 45:95−124

doi: 10.1210/endrev/bnad025

[15]

Xu H, Li Y, Gao Y. 2024. The role of immune cells settled in the bone marrow on adult hematopoietic stem cells. Cellular and Molecular Life Sciences 81:420

doi: 10.1007/s00018-024-05445-3

[16]

Andreev D, Kachler K, Liu M, Chen Z, Krishnacoumar B, et al. 2024. Eosinophils preserve bone homeostasis by inhibiting excessive osteoclast formation and activity via eosinophil peroxidase. Nature Communications 15:1067

doi: 10.1038/s41467-024-45261-8

[17]

Lu J, He Q, Wang H, Yao L, Duffy M, et al. 2025. Bone marrow adipogenic lineage precursors are the major regulator of bone resorption in adult mice. Bone Research 13:39

doi: 10.1038/s41413-025-00405-4

[18]

Kondegowda NG, Filipowska J, Do JS, Leon-Rivera N, Li R, et al. 2023. RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes. Science Advances 9:eadf5238

doi: 10.1126/sciadv.adf5238

[19]

Hennen EM, Uppuganti S, de la Visitación N, Chen W, Krishnan J, et al. 2025. Hypertension promotes bone loss and fragility by favoring bone resorption in mouse models. Journal of Clinical Investigation 135:e184325

doi: 10.1172/JCI184325

[20]

Li Q, Liu S, Sun T, Liu K, Li P, et al. 2026. Nanoparticles coated with osteoblast-like cell membranes as curcumin delivery vehicles for targeted postmenopausal osteoporosis therapy. Materials Today Bio 36:102636

doi: 10.1016/j.mtbio.2025.102636

[21]

Wang C, Zhao Q, Chen C, Li J, Zhang J, et al. 2023. CD301b⁺ macrophage: the new booster for activating bone regeneration in periodontitis treatment. International Journal of Oral Science 15:19

doi: 10.1038/s41368-023-00225-4

[22]

Hasegawa Y, Franks JM, Tanaka Y, Uehara Y, Read DF, et al. 2024. Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis. Science Advances 10:eadl4913

doi: 10.1126/sciadv.adl4913

[23]

Griffith JW, Luster AD. 2025. No bones about it: regulatory T cells promote fracture healing. Journal of Clinical Investigation 135(2):e188368

doi: 10.1172/JCI188368

[24]

Dar HY, Perrien DS, Pal S, Stoica A, Uppuganti S, et al. 2023. Callus γδ T cells and microbe-induced intestinal Th17 cells improve fracture healing in mice. Journal of Clinical Investigation 133:e166577

doi: 10.1172/JCI166577

[25]

Hofer SJ, Rapp S, Klenerman P, Simon AK. 2025. Understanding and improving vaccine efficacy in older adults. Nature Aging 5:1455−1470

doi: 10.1038/s43587-025-00939-6

[26]

Ross JB, Myers LM, Noh JJ, Collins MM, Carmody AB, et al. 2024. Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity. Nature 628:162−170

doi: 10.1038/s41586-024-07238-x

[27]

Lam N, Angel JC, Buchholz BA, Lee Y, Weisberg SP, et al. 2025. Asynchronous aging and turnover of human circulating and tissue-resident memory T cells across sites. Immunity 58:2271−2288. e6

doi: 10.1016/j.immuni.2025.07.001

[28]

Khan S, Chakraborty M, Wu F, Chen N, Wang T, et al. 2026. B cells drive CD4 T cell immunosenescence and age-associated health decline. Science Immunology 11:eadv7615

doi: 10.1126/sciimmunol.adv7615

[29]

Jiang SL, Wang D, Zou C, Zhu ZW, Luo C, et al. 2025. Macrophages at the crossroads of cellular senescence and cancer development and progression: Therapeutic opportunities and challenges. Pharmacology & Therapeutics 274:108906

doi: 10.1016/j.pharmthera.2025.108906

[30]

Liu Z, Liang Q, Ren Y, Guo C, Ge X, et al. 2023. Immunosenescence: molecular mechanisms and diseases. Signal Transduction and Targeted Therapy 8:200

doi: 10.1038/s41392-023-01451-2

[31]

Costa SN, Chlebek C, Gray L, Caradonna P, Ryzhov S, et al. 2026. Expansion of bone marrow adipocytes in obese mice leads to PD-L1-driven bone marrow immunosuppression and osteoclastogenesis. Bone Research 14:32

doi: 10.1038/s41413-026-00509-5

[32]

Zou NY, Liu R, Huang M, Jiao YR, Wei J, et al. 2024. Age-related secretion of grancalcin by macrophages induces skeletal stem/progenitor cell senescence during fracture healing. Bone Research 12:6

doi: 10.1038/s41413-023-00309-1

[33]

Ajoolabady A, Pratico D, Tang D, Zhou S, Franceschi C, et al. 2024. Immunosenescence and inflammaging: Mechanisms and role in diseases. Ageing Research Reviews 101:102540

doi: 10.1016/j.arr.2024.102540

[34]

Santoro A, Bientinesi E, Monti D. 2021. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? Ageing Research Reviews 71:101422

doi: 10.1016/j.arr.2021.101422

[35]

Dong D, Yu X, Liu H, Xu J, Guo J, et al. 2025. Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies. Seminars in Cancer Biology 111:16−35

doi: 10.1016/j.semcancer.2025.01.007

[36]

Li X, Li C, Zhang W, Wang Y, Qian P, et al. 2023. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduction and Targeted Therapy 8:239

doi: 10.1038/s41392-023-01502-8

[37]

Muñoz-Cánoves P, Scheele C, Pedersen BK, Serrano AL. 2013. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS Journal 280:4131−4148

doi: 10.1111/febs.12338

[38]

McGregor NE, Murat M, Elango J, Poulton IJ, Walker EC, et al. 2019. IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis. Journal of Biological Chemistry 294:7850−7863

doi: 10.1074/jbc.RA119.008074

[39]

Xie Z, Tang SA, Ye G, Wang P, Li J, et al. 2018. Interleukin-6/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells. Stem Cell Research & Therapy 9:13

doi: 10.1186/s13287-017-0766-0

[40]

Avery D, Morandini L, Sheakley LS, Shah AH, Bui L, et al. 2022. Canonical Wnt signaling enhances pro-inflammatory response to titanium by macrophages. Biomaterials 289:121797

doi: 10.1016/j.biomaterials.2022.121797

[41]

Lê S, Sturaro E, Thomas C, Canceill T, Ekambi B, et al. 2025. Porphyromonas gingivalis-induced glucose intolerance during periapical lesions requires its LPS throught a Th17 immune response. International Journal of Oral Science 17:69

doi: 10.1038/s41368-025-00403-6

[42]

Dasgupta N, Lei X, Shi CH, Arnold R, Teneche MG, et al. 2024. Histone chaperone HIRA, promyelocytic leukemia protein, and p62/SQSTM1 coordinate to regulate inflammation during cell senescence. Molecular Cell 84:3271−3287. e8

doi: 10.1016/j.molcel.2024.08.006

[43]

Yao Y, Cai X, Chen Y, Zhang M, Zheng C. 2025. Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis. Medicinal Research Reviews 45:561−575

doi: 10.1002/med.22081

[44]

Shi D, Tian M, Li Y, Xue M, Zhao X, et al. 2026. Bone-targeted platinum nanoframework prevents postmenopausal osteoporosis via transmembrane protein 16A channel blockade and reactive oxygen species scavenging. ACS Nano 20:1678−1694

doi: 10.1021/acsnano.5c19260

[45]

Tai KY, Chen CL, Fan SM, Kuan CH, Lin CK, et al. 2025. Adipocyte lipolysis activates epithelial stem cells for hair regeneration through fatty acid metabolic signaling. Cell Metabolism 37:2202−2219. e8

doi: 10.1016/j.cmet.2025.09.012

[46]

Moon JS, Cunha FF, Huh JY, Andreyev AY, Lee J, et al. 2021. ANT2 drives proinflammatory macrophage activation in obesity. JCI Insight 6:e147033

doi: 10.1172/jci.insight.147033

[47]

Sarachakov A, Varlamova A, Svekolkin V, Polyakova M, Valencia I, et al. 2023. Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodeling. Blood 142:2282−2295

doi: 10.1182/blood.2023021280

[48]

Wang B, Liu J, Wang Q, Arhatte M, Cheong LY, et al. 2025. Piezo1 activation suppresses bone marrow adipogenesis to prevent osteoporosis by inhibiting a mechanoinflammatory autocrine loop. Signal Transduction and Targeted Therapy 10:357

doi: 10.1038/s41392-025-02455-w

[49]

Huo S, Tang X, Chen W, Gan D, Guo H, et al. 2024. Epigenetic regulations of cellular senescence in osteoporosis. Ageing Research Reviews 99:102235

doi: 10.1016/j.arr.2024.102235

[50]

Li K, Hu S, Chen H. 2025. Cellular senescence and other age-related mechanisms in skeletal diseases. Bone Research 13:68

doi: 10.1038/s41413-025-00448-7

[51]

Li C, Xu W, Li L, Zhou Y, Yao G, et al. 2024. Concrete-inspired bionic bone glue repairs osteoporotic bone defects by gluing and remodeling aging macrophages. Advanced Science 11:e2408044

doi: 10.1002/advs.202408044

[52]

He Y, Fang D, Huang B, Chen X, Zhang Z, et al. 2026. Biomimetic hybrid nanocarriers hitchhike neutrophils for targeted ginsenoside Rc delivery to BMSCs: ameliorating postmenopausal osteoporosis via iron homeostasis regulation. Journal of Nanobiotechnology 24:439

doi: 10.1186/s12951-026-04353-x

[53]

Lu X, Zhang A, Zhang C, Guo D, Li ZA, et al. 2026. Targeting the osteoporotic bone microenvironment: Mechanistic insight and therapeutic biomaterials for accelerating bone regeneration. Bioactive Materials 62:96−122

doi: 10.1016/j.bioactmat.2026.02.024

[54]

Hall T, Gurbuxani S, Crispino JD. 2024. Malignant progression of preleukemic disorders. Blood 143:2245−2255

doi: 10.1182/blood.2023020817

[55]

Rauner M, Bozec A. 2026. Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis. Nature Reviews Rheumatology 22:42−61

doi: 10.1038/s41584-025-01323-9

[56]

Gorgun C, Klavina P, Martins CS, Payet C, Cavanagh BL, et al. 2026. Metabolic reprogramming of human macrophages drives the formation of hybrid M1/M2 pro-regenerative extracellular vesicles. Biomaterials 333:124216

doi: 10.1016/j.biomaterials.2026.124216

[57]

Isojima T, Crimeen-Irwin B, McGregor NE, Chai RC, Poulton IJ, et al. 2025. Bone marrow neutrophil progenitors suppress osteoclast formation in murine cortical and trabecular bone. Blood 146:1331−1345

doi: 10.1182/blood.2025028310

[58]

Li CJ, Xiao Y, Sun YC, He WZ, Liu L, et al. 2022. Senescent immune cells release grancalcin to promote skeletal aging. Cell Metabolism 34:184−185

doi: 10.1016/j.cmet.2021.12.003

[59]

Theret M, Saclier M, Messina G, Rossi FMV. 2022. Macrophages in skeletal muscle dystrophies, an entangled partner. Journal of Neuromuscular Diseases 9:1−23

doi: 10.3233/JND-210737

[60]

Kubat GB, Bouhamida E, Ulger O, Turkel I, Pedriali G, et al. 2023. Mitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies. Mitochondrion 72:33−58

doi: 10.1016/j.mito.2023.07.003

[61]

Ando Y, Tsukasaki M, Huynh NC, Zang S, Yan M, et al. 2024. The neutrophil-osteogenic cell axis promotes bone destruction in periodontitis. International Journal of Oral Science 16:18

doi: 10.1038/s41368-023-00275-8

[62]

Zhou J, Zhuang Z, Li J, Feng Z. 2023. Significance of the cGAS-STING pathway in health and disease. International Journal of Molecular Sciences 24:13316

doi: 10.3390/ijms241713316

[63]

Dvorkin S, Cambier S, Volkman HE, Stetson DB. 2024. New frontiers in the cGAS-STING intracellular DNA-sensing pathway. Immunity 57:718−730

doi: 10.1016/j.immuni.2024.02.019

[64]

Wang X, Sun B, Wang Y, Gao P, Song J, et al. 2024. Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases. Frontiers in Immunology 15:1333993

doi: 10.3389/fimmu.2024.1333993

[65]

Kindstedt E, Wänman M, Wu WY, Hofer-Mattsson K, Lövgren A, et al. 2026. Systemic cytokine alterations in periodontitis independent of comorbidities: a systematic review and meta-analysis. Aging and Disease

doi: 10.14336/AD.2026.0110

[66]

González-Osuna L, Sierra-Cristancho A, Rojas C, Cafferata EA, Melgar-Rodríguez S, et al. 2021. Premature senescence of T-cells favors bone loss during osteolytic diseases. a new concern in the osteoimmunology arena. Aging and Disease 12:1150−1161

doi: 10.14336/AD.2021.0110

[67]

Fischer V, Haffner-Luntzer M. 2022. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Seminars in Cell & Developmental Biology 123:14−21

doi: 10.1016/j.semcdb.2021.05.014

[68]

Frase D, Lee C, Nachiappan C, Gupta R, Akkouch A. 2023. The inflammatory contribution of B-lymphocytes and neutrophils in progression to osteoporosis. Cells 12:1744

doi: 10.3390/cells12131744

[69]

Dowery R, Benhamou D, Benchetrit E, Harel O, Nevelsky A, et al. 2021. Peripheral B cells repress B-cell regeneration in aging through a TNF-α/IGFBP-1/IGF-1 immune-endocrine axis. Blood 138:1817−1829

doi: 10.1182/blood.2021012428

[70]

Chen Y, Lin L, Ruan S, Ye J, Dai Z, et al. 2024. DNA demethylation of promoter region facilitates atoh-1-induced interleukin-19 expression activation in bone marrow monocytes of old mice. Aging and Disease 16:540−551

doi: 10.14336/AD.2024.0108

[71]

Xiong Y, Mi BB, Lin Z, Hu YQ, Yu L, et al. 2022. The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity. Military Medical Research 9:65

doi: 10.1186/s40779-022-00426-8

[72]

Wen Y, Zheng X, Li J, He M, Fan D, et al. 2026. Hyperviscous diabetic bone marrow niche impairs BMSCs osteogenesis via TRPV2-mediated cytoskeletal-nuclear mechanotransduction. Advanced Science 13:e09056

doi: 10.1002/advs.202509056

[73]

Zhang M, Meng L, Li X, Zhang Y, Yuan R, et al. 2026. Senescent CD4⁺ T cells drive diabetic periodontitis via JAK-STAT-ROS-p38 MAPK. Journal of Dental Research 105:1174−1185

doi: 10.1177/00220345251400253

[74]

Wang ZX, Luo ZW, Li FX, Cao J, Rao SS, et al. 2022. Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox. Nature Communications 13:1453

doi: 10.1038/s41467-022-29191-x

[75]

Su T, He Y, Huang Y, Ye M, Guo Q, et al. 2024. Myeloid-derived grancalcin instigates obesity-induced insulin resistance and metabolic inflammation in male mice. Nature Communications 15:97

doi: 10.1038/s41467-023-43787-x

[76]

Man K, Kallies A, Vasanthakumar A. 2022. Resident and migratory adipose immune cells control systemic metabolism and thermogenesis. Cellular & Molecular Immunology 19:421−431

doi: 10.1038/s41423-021-00804-7

[77]

de Jong MME, Kellermayer Z, Papazian N, Tahri S, Hofste Op Bruinink D, et al. 2021. The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nature Immunology 22:769−780

doi: 10.1038/s41590-021-00931-3

[78]

Dzamukova M, Brunner TM, Miotla-Zarebska J, Heinrich F, Brylka L, et al. 2022. Mechanical forces couple bone matrix mineralization with inhibition of angiogenesis to limit adolescent bone growth. Nature Communications 13:3059

doi: 10.1038/s41467-022-30618-8

[79]

Zhang L, Guan Q, Wang Z, Feng J, Zou J, et al. 2023. Consequences of Aging on Bone. Aging and Disease 15:2417−2452

doi: 10.14336/AD.2023.1115

[80]

Yan C, Zhang P, Qin Q, Jiang K, Luo Y, et al. 2024. 3D-printed bone regeneration scaffolds modulate bone metabolic homeostasis through vascularization for osteoporotic bone defects. Biomaterials 311:122699

doi: 10.1016/j.biomaterials.2024.122699

[81]

Mauro D, Gandolfo S, Tirri E, Schett G, Maksymowych WP, et al. 2023. The bone marrow side of axial spondyloarthritis. Nature Reviews Rheumatology 19:519−532

doi: 10.1038/s41584-023-00986-6

[82]

Li J, Guo C, Yang X, Xie W, Mi W, et al. 2025. Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases. Pharmacological Research 213:107634

doi: 10.1016/j.phrs.2025.107634

[83]

Chen J, Liu B, Yao X, Yang X, Sun J, et al. 2025. AMPK/SIRT1/PGC-1α signaling pathway: Molecular mechanisms and targeted strategies from energy homeostasis regulation to disease therapy. CNS Neuroscience & Therapeutics 31:e70657

doi: 10.1111/cns.70657

[84]

Spaulding HR, Yan Z. 2022. AMPK and the adaptation to exercise. Annual Review of Physiology 84:209−227

doi: 10.1146/annurev-physiol-060721-095517

[85]

Wang D, Zhong D, He Y, Xie J, Ruan D, et al. 2026. Intercellular communication-driven mitochondrial transfer via CXCR4-engineered macrophages reprograms bone marrow metabolism for osteoporosis therapy. Advanced Materials 38:e21645

doi: 10.1002/adma.202521645

[86]

Fernandes IG, Oliveira LM, Andrade MMS, Alberca RW, Lima JC, et al. 2025. Resveratrol upregulates antioxidant factors expression and downmodulates interferon-inducible antiviral factors in aging. International Journal of Molecular Sciences 26:2345

doi: 10.3390/ijms26052345

[87]

Lee YH, So BH, Lee KS, Kuk MU, Park JH, et al. 2024. Identification of cellular isoschaftoside-mediated anti-senescence mechanism in RAC2 and LINC00294. Molecules 29:4182

doi: 10.3390/molecules29174182

[88]

Wang L, Wang J, Yang Z, Wang Y, Zhao T, et al. 2023. Traditional herbs: mechanisms to combat cellular senescence. Aging 15:14473−14505

doi: 10.18632/aging.205269

[89]

Cao Z, Wang Z, Yang L, Li T, Tao X, et al. 2025. Reshaping the immune microenvironment and reversing immunosenescence by natural products: Prospects for immunotherapy in gastric cancer. Seminars in Cancer Biology 110:1−16

doi: 10.1016/j.semcancer.2025.02.002

[90]

Long J, Lai H, Huang Y, You F, Jiang Y, et al. 2025. Unraveling the pathogenesis of bone marrow hematopoietic injury and the therapeutic potential of natural products. Pharmacological Research 212:107589

doi: 10.1016/j.phrs.2025.107589

[91]

Yao J, Liu J, He Y, Liu L, Xu Z, et al. 2023. Systems pharmacology reveals the mechanism of Astragaloside IV in improving immune activity on cyclophosphamide-induced immunosuppressed mice. Journal of Ethnopharmacology 313:116533

doi: 10.1016/j.jep.2023.116533

[92]

Li JY, Yi C, Zhu MQ, Yuan YF, Chen G, et al. 2025. Immunomodulatory actions of tonifying polysaccharides: pharmacological effects, mechanisms and therapeutic applications. Frontiers in Immunology 16:1640679

doi: 10.3389/fimmu.2025.1640679

[93]

Luo J, Zhang Z, Jin L, Wang Z, Sun Q, et al. 2025. The effect of gallic acid on the alleviation of the chemotherapyinduced myelosuppression. Current Medicinal Chemistry 32:8400−8416

doi: 10.2174/0109298673354122241220051407

[94]

Pang Y, Zhu S, Ding P, Zhang S, Zhang Y, et al. 2025. Long-term high-fat diet affected bone marrow microenvironment during aging at single-cell resolution. MedComm 6:e70276

doi: 10.1002/mco2.70276

[95]

Wu Y, Liu Y, Xu Y, Zheng A, Du J, et al. 2022. Bioactive natural compounds as potential medications for osteogenic effects in a molecular docking approach. Frontiers in Pharmacology 13:955983

doi: 10.3389/fphar.2022.955983

[96]

Li D, Yin W, Xu C, Feng Y, Huang X, et al. 2024. Rutin promotes osteogenic differentiation of mesenchymal stem cells (MSCs) by increasing ECM deposition and inhibiting p53 expression. Aging 16:3583−3595

doi: 10.18632/aging.205546

[97]

Scarpa ES, Amatori S, Caprioli G, Maggi F, Moroncini G, et al. 2025. Innovative therapeutic approaches targeting obesity: can flavonoids improve the efficacy of anti-obesogenic drugs? International Journal of Molecular Sciences 26:10142

doi: 10.3390/ijms262010142

[98]

Karadeniz F, Oh JH, Jang MS, Seo Y, Kong CS. 2022. Libanoridin isolated from corydalis heterocarpa inhibits adipogenic differentiation of bone marrow-derived mesenchymal stromal cells. International Journal of Molecular Sciences 24:254

doi: 10.3390/ijms24010254

[99]

Wang F, Yang S, Zhu Y, Zhang Y, He W, et al. 2025. Mechanical energy-charged navigating pump repair natural vascular scaffolds to reverse osteoporosis. Materials Today Bio 35:102431

doi: 10.1016/j.mtbio.2025.102431

[100]

Wang R, He X, Bai J, Su S, Liu H, et al. 2026. Microenvironment-engineered hydrogels drive osteo-angiogenic coupling to accelerate osteoporotic bone regeneration. Biomaterials 329:123966

doi: 10.1016/j.biomaterials.2025.123966

[101]

Fan D, Lu J, Yu N, Xie Y, Zhen L. 2022. Curcumin prevents diabetic osteoporosis through promoting osteogenesis and angiogenesis coupling via NF-κB signaling. Evidence-Based Complementary and Alternative Medicine 2022:4974343

doi: 10.1155/2022/4974343

[102]

Li Z, Li Y, Liu C, Gu Y, Han G. 2024. Research progress of the mechanisms and applications of ginsenosides in promoting bone formation. Phytomedicine 129:155604

doi: 10.1016/j.phymed.2024.155604

[103]

Wang R, He X, Su S, Bai J, Liu H, et al. 2024. Multifunctional tannic acid-based nanocomposite methacrylated silk fibroin hydrogel with the ability to scavenge reactive oxygen species and reduce inflammation for bone regeneration. International Journal of Biological Macromolecules 266:131357

doi: 10.1016/j.ijbiomac.2024.131357

[104]

Penzes N, Omelka R, Sarocka A, Biro R, Kovacova V, et al. 2026. Therapeutic effects of the most common polyphenols found in sorbus domestica L. fruits on bone health. Nutrients 18:267

doi: 10.3390/nu18020267

[105]

Chen T, Jin L, Li J, Liu Y. 2024. Pyroptosis mediates osteoporosis via the inflammation immune microenvironment. Frontiers in Immunology 15:1371463

doi: 10.3389/fimmu.2024.1371463

[106]

Liang M, Zhou L, Li J, Liang B, Zhou L, et al. 2025. An acid-responsive bone-targeting nanoplatform loaded with curcumin balances osteogenic and osteoclastic functions. Regenerative Biomaterials 12:rbaf028

doi: 10.1093/rb/rbaf028

[107]

Du Q, Zhang Z, Tu Y, Zheng X, Peng X, et al. 2026. Berberine ameliorates estrogen deficiency-associated bone loss via inducing tuft cell expansion. Phytomedicine 155:158058

doi: 10.1016/j.phymed.2026.158058

[108]

Chen F, Geng W, Wang Y, Lai X, Liu B, et al. 2026. Isoeugenol suppression of osteoporosis by modulating macrophage M1 Polarization via p38 MAPK and arachidonic acid metabolism pathways. Phytomedicine 155:158116

doi: 10.1016/j.phymed.2026.158116

[109]

Sun X, Xie Z, Hu B, Zhang B, Ma Y, et al. 2020. The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling. Redox Biology 28:101309

doi: 10.1016/j.redox.2019.101309

[110]

Lin F, Chen J, Chen M, Lin S, Dong S. 2023. Protective effect and possible mechanisms of resveratrol in animal models of osteoporosis: a preclinical systematic review and meta-analysis. Phytotherapy Research 37:5223−5242

doi: 10.1002/ptr.7954

[111]

Azam Z, Sapra L, Baghel K, Sinha N, Gupta RK, et al. 2023. Cissus quadrangularis (hadjod) inhibits RANKL-induced osteoclastogenesis and augments bone health in an estrogen-deficient preclinical model of osteoporosis via modulating the host osteoimmune system. Cells 12:216

doi: 10.3390/cells12020216

[112]

Wan L, Li S, Du J, Li A, Zhan Y, et al. 2025. Review of metal-polyphenol self-assembled nanoparticles: synthesis, properties, and biological applications in inflammatory diseases. ACS Biomaterials Science & Engineering 11:2502−2527

doi: 10.1021/acsbiomaterials.4c02366

[113]

Khan A, Sabella H, Mandlem VKK, Deba F. 2025. Salvianolic acid-A alleviates oxidative stress-induced osteoporosis. Life Sciences 375:123727

doi: 10.1016/j.lfs.2025.123727

[114]

Cao S, Wang Y, Zhang Y, Ren J, Fan B, et al. 2024. Naringenin can inhibit the pyroptosis of osteoblasts by activating the Nrf2/HO-1 signaling pathway and alleviate the differentiation disorder of osteoblasts caused by microgravity. Journal of Agricultural and Food Chemistry 72:25586−25600

doi: 10.1021/acs.jafc.4c05370

[115]

Chen Z, Encarnacion AM, Rajan RPS, Yao H, Lee S, et al. 2024. Discovery of a novel homoisoflavonoid derivative 5g for anti-osteoclastic bone loss via targeting FGFR1. European Journal of Medicinal Chemistry 270:116335

doi: 10.1016/j.ejmech.2024.116335

[116]

Wang L, Qu Y, Hu Z, Lei P, Tian X, et al. 2025. Kaempferol ameliorates BMSCs senescence in postmenopausal osteoporosis by targeting Sp1 to activate FUNDC1-mediated mitophagy. Phytomedicine 148:157456

doi: 10.1016/j.phymed.2025.157456

[117]

Wu Y, Wang P, Wu S, Xu H, Yang W, et al. 2026. Bridging pharmacology and nanotechnology: mechanistic insights into traditional Chinese medicine-based nanodelivery systems for rheumatoid arthritis. International Journal of Nanomedicine 21:574688

doi: 10.2147/IJN.S574688

[118]

Wang H, Geng X, Ai F, Yu Z, Zhang Y, et al. 2024. Nuciferine alleviates collagen-induced arthritic in rats by inhibiting the proliferation and invasion of human arthritis-derived fibroblast-like synoviocytes and rectifying Th17/Treg imbalance. Chinese Journal of Natural Medicines 22:341−355

doi: 10.1016/S1875-5364(24)60622-9

[119]

Zou B, Zheng J, Deng W, Tan Y, Jie L, et al. 2021. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca²⁺-NFATc1 and Cav-1 signaling pathways. Phytomedicine 80:153377

doi: 10.1016/j.phymed.2020.153377

[120]

Zhao C, Wu F, Zhao L, Zhong J, Huang C, et al. 2025. Corosolic acid modulates RANKL-triggered signaling to suppress osteoclastogenesis and ovariectomy-induced bone loss. Free Radical Biology and Medicine 241:882−898

doi: 10.1016/j.freeradbiomed.2025.10.284

[121]

Yue H, Tian Y, Li Y, Bai X, Wang X, et al. 2022. Comparative study of holothurin A and echinoside A on inhibiting the high bone turnover via downregulating PI3K/AKT/β-catenin and OPG/RANKL/NF-κB signaling in ovariectomized mice. Food & Function 13:4748−4756

doi: 10.1039/d1fo04357a

[122]

Shi L, Ren L, Li J, Liu X, Lu J, et al. 2024. Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss. Chinese Journal of Natural Medicines 22:212−223

doi: 10.1016/S1875-5364(24)60596-0

[123]

Huang J, Yin H, Rao SS, Xie PL, Cao X, et al. 2018. Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice. Theranostics 8:2435−2446

doi: 10.7150/thno.22144

[124]

Wong P, Lv Z, Li J, Wei Q, Xu L, et al. 2022. A novel RANKL-targeted furoquinoline alkaloid ameliorates bone loss in ovariectomized osteoporosis through inhibiting the NF-κB signal pathway and reducing reactive oxygen species. Oxidative Medicine and Cellular Longevity 2022:5982014

doi: 10.1155/2022/5982014

[125]

Zhang H, Zhao X, Wang Z, Miao J, Hu X, et al. 2026. Crebanine protects against ovariectomy-induced bone loss by targeting Sirt1 to interfere with NF-κB acetylation and ROS activity. Journal of Pharmaceutical Analysis 16:101426

doi: 10.1016/j.jpha.2025.101426

[126]

Bu T, Zhao X, Kong X, Huang Z, Zhu H, et al. 2026. The mechanism of dendrobium officinale polysaccharides in alleviating osteoporosis via regulation of Wnt/β-catenin signaling pathways and modulation of gut microbiota. Journal of Agricultural and Food Chemistry 74:713−730

doi: 10.1021/acs.jafc.5c10301

[127]

Sun X, Wei B, Peng Z, Fu Q, Wang C, et al. 2019. Protective effects of Dipsacus asper polysaccharide on osteoporosis in vivo by regulating RANKL/RANK/OPG/VEGF and PI3K/Akt/eNOS pathway. International Journal of Biological Macromolecules 129:579−587

doi: 10.1016/j.ijbiomac.2019.02.022

[128]

Zhao M, Xiang J, Meng Y, Sun H, Yang W, et al. 2025. Astragalus Polysaccharide hydrogels with drug-carrying super self-assembly from natural herbs promote wound healing. ACS Nano 19:21571−21588

doi: 10.1021/acsnano.5c03744

[129]

Niu P, Zhao L, Yang J, Ding Y, Xu X, et al. 2025. Self-assembled nanoparticles with well-defined oligosaccharide promote osteogenesis by regulating golgi stress response. Advanced Healthcare Materials 14:e2402976

doi: 10.1002/adhm.202402976

[130]

Sun J, Xu F, Yao X, Niu X, Shen Y, et al. 2026. Tectorigenin alleviates diabetic lung injury by restoring gut microbiota and metabolic homeostasis. Biochemical Pharmacology 243:117545

doi: 10.1016/j.bcp.2025.117545

[131]

Sun T, Li Q, Cheng H, Zhang W, Han N, et al. 2026. Bone tissue engineering scaffolds for bone aging: drug delivery and microenvironment regulation. Tissue Engineering Part B: Reviews :19373341251379774

doi: 10.1177/19373341251379774

[132]

Iga T, Kobayashi H, Kusumoto D, Sanosaka T, Fujita N, et al. 2023. Spatial heterogeneity of bone marrow endothelial cells unveils a distinct subtype in the epiphysis. Nature Cell Biology 25:1415−1425

doi: 10.1038/s41556-023-01240-7

[133]

Bandyopadhyay S, Duffy MP, Ahn KJ, Sussman JH, Pang M, et al. 2024. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell 187:3120−3140. e29

doi: 10.1016/j.cell.2024.04.013

[134]

Micheletti C, Shah FA, Palmquist A, Grandfield K. 2023. Ultrastructure and nanoporosity of human bone shown with correlative on-axis electron and spectroscopic tomographies. ACS Nano 17:24710−24724

doi: 10.1021/acsnano.3c04633

[135]

Lin W, Li Y, Qiu C, Zou B, Gong Y, et al. 2025. Mapping the spatial atlas of the human bone tissue integrating spatial and single-cell transcriptomics. Nucleic Acids Research 53:gkae1298

doi: 10.1093/nar/gkae1298

[136]

Enninful A, Zhang Z, Klymyshyn D, Ingalls M, Yang M, et al. 2026. Integration of imaging-based and sequencing-based spatial omics mapping on the same tissue section via DBiTplus. Nature Methods

doi: 10.1038/s41592-025-02948-0

[137]

Quan H, He Y, Xiao P, Zhu Z, Zhou X, et al. 2025. Scaffold-mediated microenvironmental modulation targeting osteoclasts for onfh niche reprogramming. Research 8:1027

doi: 10.34133/research.1027

[138]

Koblan LW, Yost KE, Zheng P, Colgan WN, Jones MG, et al. 2025. High-resolution spatial mapping of cell state and lineage dynamics in vivo with PEtracer. Science 390:eadx3800

doi: 10.1126/science.adx3800

[139]

Chen M, Fu R, Chen Y, Li L, Wang SW. 2025. High-resolution, noninvasive single-cell lineage tracing in mice and humans based on DNA methylation epimutations. Nature Methods 22:488−498

doi: 10.1038/s41592-024-02567-1

[140]

Long J, Huang W, Dai Z, Kuang Q, Jiang Y, et al. 2025. Reconstruction of hematopoietic stem cell niches in vitro: Cutting-edge strategies and application prospects. Materials Today Bio 35:102536

doi: 10.1016/j.mtbio.2025.102536

[141]

Frenz-Wiessner S, Fairley SD, Buser M, Goek I, Salewskij K, et al. 2024. Generation of complex bone marrow organoids from human induced pluripotent stem cells. Nature Methods 21:868−881

doi: 10.1038/s41592-024-02172-2

[142]

Georgescu A, Oved JH, Galarraga JH, Cantrell T, Mehta S, et al. 2024. Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip. Cell Stem Cell 31:1847−1864. e6

doi: 10.1016/j.stem.2024.11.003

[143]

Ayupova R, Svajdlenka E, Zemlicka M, Ibadullayeva G, Raganina K, et al. 2025. Comparative phytochemical profiling of essential oils from selected abies species and analysis of their antifungal and antiradical activity. Pharmaceutics 18:26

doi: 10.3390/pharmaceutics18010026

[144]

Mikropoulou EV, Basdeki A, Halabalaki M. 2026. Metabolism and bioavailability aspects of natural products of plant origin using mass spectrometry-based and metabolomic approaches. Natural Product Reports 43:1130−1180

doi: 10.1039/d5np00022j

[145]

Mu Y, Du Z, Gao W, Xiao L, Crawford R, et al. 2024. The effect of a bionic bone ionic environment on osteogenesis, osteoimmunology, and in situ bone tissue engineering. Biomaterials 304:122410

doi: 10.1016/j.biomaterials.2023.122410

[146]

Chen J, Luo J, Feng J, Wang Y, Lv H, et al. 2024. Spatiotemporal controlled released hydrogels for multi-system regulated bone regeneration. Journal of Controlled Release 372:846−861

doi: 10.1016/j.jconrel.2024.06.065

[147]

Sun J, Chen J, Shen Y, Yao X, Sun H, et al. 2025. Diabetes mellitus-driven pulmonary injury: multidimensional mechanisms linking metabolic dysregulation to gut-lung axis and promising therapies. Frontiers in Pharmacology 16:1689522

doi: 10.3389/fphar.2025.1689522

[148]

Wu X, Wang T, Zhao J, Zhang L, Liu Z, et al. 2025. Ultrasound-responsive piezoelectric membrane promotes osteoporotic bone regeneration via the "two-way regulation" bone homeostasis strategy. Advanced Science 12:e2504293

doi: 10.1002/advs.202504293